Pharmafile Logo

toothbrush

National Institute for Health and Care Excellence NICE logo

Remicade, Humira and Simponi face NICE knock-back

Draft guidance does not recommend the drugs for ulcerative colitis

- PMLiVE

AZ sets up joint lab with Cancer Research UK

Five-year collaboration will drive charity’s research programmes

- PMLiVE

Gilead will file safer HIV combination before year-end

New version of Stribild is less likely to cause side effects

- PMLiVE

Celgene’s Otezla gains new US psoriasis approval

FDA backs oral drug in moderate to severe plaque psoriasis

- PMLiVE

Almac Group appoints two marketing directors

Matt Cocking and Laura Montgomery join the contract development and manufacturing company

- PMLiVE

Almost half of cancer patients diagnosed ‘too late’

Cancer Research UK claims 46% are diagnosed at advanced stage

- PMLiVE

Moral diversity in healthcare

Should religious or moral beliefs influence a doctor's decision?

- PMLiVE

Ogilvy expands its pharma offering in the Middle East and North Africa

New Dubai operation will be led by Karen Kamel

- PMLiVE

NICE backs Celgene’s Revlimid in rare blood cancer

Patient access scheme sways the HTA body

Sir Philip Hampton set to be new GSK chair

RBS chairman to replace Sir Christopher Gent

- PMLiVE

Boehringer cuts up to 600 jobs in Germany

Says cutbacks are due to strict drug reimbursement in home nation

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links